Skip to content
  • Contacts
  • facebook
  • twitter
  • linkedin
registration | login

News and Events

The official online journal of the International Conference
on Thrombosis and Hemostasis Issues in Cancer
WEBINAR: Challenges in the management of fragile CAT patients (older patient population & palliative care) by ICTHIC Editorial Office 9 March 2023
Abstract submission deadline for ESMO Breast Cancer Congress by ICTHIC Editorial Office 15 February 2023
Abstract submission now open for ESMO 2023 by ICTHIC Editorial Office 15 February 2023
31th Congress of the International Society on Thrombosis and Haemostasis by ICTHIC Editorial Office 9 February 2023
  • Home
  • Thrombosis and cancer
    • Epidemiology
    • Basic Mechanisms
    • Prevention
    • Trials and Therapy
    • Focus on: Atrial fibrillation
    • Focus on: Pediatrics
    • Focus on: COVID-19
  • Guidelines and Tools
  • Congress reports
    • ICTHIC 2022
    • ICTHIC 2021
    • ISTH 2020
    • ASH 2020
    • ASH 2019
    • ISTH 2019
    • ICTHIC 2018
    • ESC 2018
  • News and Events
  • Past webinars
  • About
  • Contacts
  • Editorial Board
  • Most Read
  • Podcast and videos
  • Archive
  • PARTNERSHIP
Webinar

Home › Anticoagulation Drugs

Anticoagulation Drugs

The Impact of DDI on the Cancer Patient

Cancer patients are often prescribed more than one drug and the need to elucidate potential harmful interactions...
Author ICTHIC Editorial OfficePosted on 22 December 202222 December 2022

Management of VTE beyond 12 months in patients with cancer-associated thrombosis

During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...
Author ICTHIC Editorial OfficePosted on 7 November 202219 January 2023

The impact of warfarin on overall survival in cancer patients with VTE

During the 11th ICTHIC, 2022, Jeffrey Zwicker talked about the impact of warfarin on overall survival (OS) in cancer...
Author ICTHIC Editorial OfficePosted on 26 July 202225 July 2022

Low-dose apixaban as secondary prophylaxis in patients with cancer: is it safe?

Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...
Author ICTHIC Editorial OfficePosted on 20 February 202221 February 2022

Does warfarin increase overall survival compared to LMWH in CAT treatment?

The treatment of cancer-associated thrombosis (CAT) has changed over the last 20 years, going from warfarin up to the...
Author ICTHIC Editorial OfficePosted on 13 December 202113 January 2022

Use of direct oral anticoagulants in patients with atrial fibrillation and concomitant active cancer

Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...
Author ICTHIC Editorial OfficePosted on 8 July 202125 January 2023

Does the use of direct oral anticoagulants improve adherence compared to low-molecular-weight heparin (LMWH) in patients with cancer?

Patients with cancer represent a major challenge for venous thromboembolism (VTE) treatment because of their higher...
Author ICTHIC Editorial OfficePosted on 17 June 2021

Use of tinzaparin in CAT patients with metastatic disease: a post hoc analysis of the CATCH trial

Introduction The management of cancer-associated thrombosis (CAT) is tricky because of the high risk of recurrent...
Author ICTHIC Editorial OfficePosted on 11 March 202118 March 2021

Venous thromboembolism: News from the Annual Meeting of the American Society of Hematology (ASH) on prevention and treatment

The Annual Meeting of the American Society of Hematology (ASH) was held on 7−10 December 2019 in Orlando (FL, USA)....
Author Anna FalangaPosted on 16 March 202027 March 2020

ICTHIC magazine is supported by the unrestricted educational grant from

SUBSCRIBE TO OUR NEWSLETTER

I agree to receive updates concerning the content published in ICTHIC MAGAZINE and related promotional content/activities (more details)

logo polistudium
Scientific and Web contents by Polistudium s.r.l.
Via Anfossi 36, 20135 Milan, Italy
info@polistudium.it
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor
© COPYRIGHT 2019 ICTHIC Magazine
Privacy policy
None of the information published on the ICTHC magazine website, in particular, information related to the choice and use of drugs, replaces the advice of a doctor.

Accept to continue
By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC Magazine, in order to receive email messages concerning the content published in ICTHIC Magazine and related promotional content/activities. Your email address may also be added to this list as a result of signing up to this Website. Personal Data collected: email address, first name, last name, profession.
ICTHIC CONFERENCE Newsletter By registering to the newsletter, the User’s email address will be added to the contact list of ICTHIC, in order to receive newsletters concerning the conference, such as Save the date, information about the meeting venue, the publication of the program, registration fees and deadline, abstract submission deadline and oral communication/poster instructions, hotel booking availability and deadline, social program for accompanying persons, the publication of speakers slides, photo/videogallery of the last edition and information about future editions of the conference. Your email address may also be added to this list as a result of signing up to this Website.